SCA
TARO

SAC Capital Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

SAC Capital Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,701
Closed -$465K – 2015
2013
Q4 		$465K Sell
4,701
-943
-17% -$81.8K ﹤0.01% 1204
2013
Q3 		$429K Buy
+5,644
New +$366K ﹤0.01% 1218

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SAC Capital Advisors's TARO Position: Q1 2014 in Review

SAC Capital Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2014, closing a stake of 4,701 shares — an estimated $465K sold.

SAC Capital Advisors first reported a position in TARO in Q3 2013 and held it in 2 quarters. The position peaked at $465K in Q4 2013. 66 funds tracked by Wall St. Rank hold TARO as of Q1 2014.

  • SAC Capital Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 4,701 Taro Pharmaceutical Industries Ltd. shares in Q1 2014, an estimated $465K.
  • SAC Capital Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 2 quarters.
  • SAC Capital Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $465K in Q4 2013.
  • 66 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.